Adopting a personalized approach to supplement selection is also critical
Similar content being viewed by others Background Metabolic syndrome is a complex metabolic disorder characterized by the manifestation of at least three concomitant clinical conditions among hypertension, obesity, hyperglycemia, hypertriglyceridemia, and hypercholesterolemia [1,2,3]
Unlike GLP-1, GIP can promote glucagon secretion in normal and hypoglycemic states, and inhibit it in hyperglycemia, thus acting as a bifunctional hormone to maintain blood glucose homeostasis
Not exogenous IGF-1 analogs that suppress those pathways entirely
Be sure to also report any side effects to them to ensure safe, effective use